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Abstract
Severe Plasmodium falciparum malaria is a major cause of global mortality, yet the immunological factors underlying
progression to severe disease remain unclear. CD4
+CD25
+ regulatory T cells (Treg cells) are associated with impaired T cell
control of Plasmodium spp infection. We investigated the relationship between Treg cells, parasite biomass, and P.
falciparum malaria disease severity in adults living in a malaria-endemic region of Indonesia. CD4
+CD25
+Foxp3
+CD127
lo Treg
cells were significantly elevated in patients with uncomplicated (UM; n=17) and severe malaria (SM; n=16) relative to
exposed asymptomatic controls (AC; n=10). In patients with SM, Treg cell frequency correlated positively with parasitemia
(r=0.79, p=0.0003) and total parasite biomass (r=0.87, p,0.001), both major determinants for the development of severe
and fatal malaria, and Treg cells were significantly increased in hyperparasitemia. There was a further significant correlation
between Treg cell frequency and plasma concentrations of soluble tumor necrosis factor receptor II (TNFRII) in SM. A subset
of TNFRII
+ Treg cells with high expression of Foxp3 was increased in severe relative to uncomplicated malaria. In vitro, P.
falciparum–infected red blood cells dose dependently induced TNFRII
+Foxp3
hi Treg cells in PBMC from malaria-unexposed
donors which showed greater suppressive activity than TNFRII
2 Treg cells. The selective enrichment of the Treg cell
compartment for a maximally suppressive TNFRII
+Foxp3
hi Treg subset in severe malaria provides a potential link between
immune suppression, increased parasite biomass, and malaria disease severity. The findings caution against the induction of
TNFRII
+Foxp3
hi Treg cells when developing effective malaria vaccines.
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Introduction
Infection with Plasmodium falciparum causes over 1 million deaths
each year and an effective malaria vaccine remains elusive. The
cellular immune responses controlling parasite replication and
disease severity in falciparum malaria are not fully understood.
Natural Treg cells characterized by the expression of the
transcription factor forkhead box P3 (Foxp3) [1,2], the IL-2
receptor a chain CD25 [3] and low expression levels of the IL-7
receptor a (CD127) [4,5], are widely accepted to be a specialized
immunosuppressive subpopulation of CD4
+ T cells [2]. Treg cells
suppress cellular immune responses through direct contact with
immune effector cells and via the production of regulatory
cytokines, including IL-10 [6,7]. Whilst it is understood that
effector T cell responses are important components of host anti-
parasitic immunity [8,9], the role of Treg cells as suppressors of T
cell responses in malaria remains unclear. In mouse experimental
malaria models, Treg cells have been associated with increased
[10,11] or delayed [12] disease progression. Importantly, in each
of these studies, Treg depletion was associated with improved
control of parasite growth.
Pre-clinical blood stage P. falciparum infection initiated by
sporozoite challenge results in an expansion of Treg cell numbers
in malaria-naı ¨ve, adult volunteers associated with increased
parasite replication [13]. Studies of natural infection are limited,
but have shown that Treg cell numbers are increased in neonates
born to mothers with placental P. falciparum malaria [14] and, in a
cohort study in a malaria-endemic region of Kenya, higher
baseline Treg cell numbers are associated with an increased risk of
subsequent development of clinical malaria [15]. Recent studies
have demonstrated a functional deficit in Treg cells in Fulani, an
ethnic group with lesser parasitization and a lower risk of clinical
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role for Treg cells in the development of clinical malaria, with
suppression of T cell-mediated control of parasite replication a
plausible explanation [13]. The role of Treg cells in modifying
disease severity in malaria is currently unknown and their
relationship to parasite biomass has not been examined. The
latter has fundamental implications for clinical presentation since
parasite replication and biomass are major determinants of the
development of severe and fatal malaria [17–19].
To better understand the role of Treg cells in disease
progression/severity and their relationship with parasite biomass,
we examined Treg cell frequency, phenotype and function in
adults with uncomplicated (UM) or severe falciparum malaria
(SM) in a malaria-endemic area of Papua, Indonesia. Our findings
indicate that increased Treg cell numbers are strongly associated
with peripheral parasitemia and parasite biomass in severe disease,
providing a plausible explanation for a key role of Treg cells in
parasite replication and disease severity. Furthermore, we
observed an altered Treg cell phenotype in severe disease, with
the induction of a TNFRII
+ population recently associated with
‘maximally suppressive’ activity in animal models [20]. The
functional consequences of this finding may underlie progression
to hyperparasitemia and severe disease.
Results
Study cohort
PBMC from 33 adult patients with P. falciparum malaria (17 with
UM, 16 with SM), and 10 malaria exposed asymptomatic control
(AC) residents were studied (Table 1). Peripheral blood parasit-
emia and total parasite biomass were each significantly higher in
SM patients, compared to UM patients (p=0.004 and 0.002
respectively, Table 1). A Coulter count of absolute lymphocytes in
whole blood showed no significant differences between control
subjects and the UM or SM patients (Table 1). Flow cytometry
analysis also did not demonstrate a significant difference in the
percentage of CD4
+ T cells of lymphocytes among these groups
(Table 1).
Treg cell frequency is increased in UM and SM
Treg cells were identified by flow cytometry as CD4
+ T cells
expressing Foxp3, CD25, and low levels of CD127 (Figure 1A) and
are reported as a percentage of total CD4
+ T cells. Treg cell
frequency was significantly increased in both UM and SM patients
(median 1.8% [IQR: 1.1–3.0%] and 2.1% [IQR: 1.0–3.8%],
respectively) relative to AC subjects (median 0.52% [IQR: 0.4–
1.2%]); Figure 1B, p=0.006. Absolute Treg cell counts were
available for all AC and 11 UM and 11 SM subjects: there were no
significant difference in Treg cell frequencies (Figure 1B) or
absolute Treg cell numbers between UM and SM patients (median
7.1610
6/L [IQR: 4.7–11.9610
6/L] and 5.3 [3.3–12.1610
6/L],
respectively; p=0.6). Therefore, the number and frequency of
Treg cells increased in malaria patients, relative to controls, but
did not vary with disease severity.
Activated antigen-experienced effector/memory CD4 T cells
were determined as CD4
+ T cells expressing the activation marker
CD25 that did not co-express Foxp3 together with low levels of
CD127 [4,21]. Differences in frequencies and absolute numbers of
activated CD4 T cells were not significant between AC (median
8% [IQR: 6.7–11.6%] and 37.7610
6/L [IQR: 27.1–52.4610
6/
L], respectively), UM (median 11.6% [IQR: 9.6–13.7] and
54.1610
6/L [IQR: 26.8–75.2610
6/L], respectively) and SM
groups (median 11.7% [IQR: 7.2–14%] and 38.2610
6/L [IQR:
18.7–75.6610
6/L], respectively); p=0.3 and 0.8, respectively.
Consequently, significantly lower ratios of activated CD4 T cells :
Treg cell numbers were detected in patients with UM and SM
compared to the AC subjects (Figure 1C; p=0.007).
Author Summary
Malaria is a major global health problem responsible for
more than 1 million deaths annually. Severity of malaria
disease is associated with the inability of host immune
cells to efficiently eliminate malaria parasites from the
blood. Little is known about immune regulatory factors
controlling the onset of severe and potentially fatal
malaria. Regulatory T (Treg) cells are a small specialized
subset of immune cells that suppress the activation and
expansion of effector immune cells which partake in
parasite elimination. We investigated the relationship
between Treg cells, parasite burden, and disease severity
in adult malaria patients with either uncomplicated or
severe malaria. We demonstrated that Treg cell frequency
was elevated in malaria patients and associated with high
parasite burden in severe malaria but not in uncomplicat-
ed malaria. Comparison of Treg cell characteristics allowed
us to identify a new highly suppressive subset of Treg cells
that was elevated in severe malaria patients. Our results
indicate that severe malaria is accompanied by the
induction of highly suppressive Treg cells that can
promote parasite growth and caution against the induc-
tion of these Treg cells when developing effective malaria
vaccines.
Table 1. Characteristics of subjects providing PBMC for Treg cell evaluation.
Asymptomatic Malaria-Exposed
Control (AC) n=10
Uncomplicated
Malaria (UM) n=17
Severe Malaria
(SM) n=16
Median age (interquartile range) 25 (19–31) 27 (22–33) 26 (19–39)
Female/Male 1/9 6/11 5/11
Median P. falciparum/mL (interquartile range) 31 (0–148) 3,500 (700–17,900) 128,000 (3,500–473,000)
Plasma PfHRP2 levels ng/mL Median (interquartile range) 0.6 (0.6–0.6)
a 124 (0.9–170) 12,400 (4,800–33,800)
Median lymphocyte count 10
9/L (interquartile range)
b 1.75 (0.7–2.1) 1.1 (0.6–1.7) 1.5 (0.8–2.0)
Median % CD4
+ T cells/lymphocytes (interquartile range) 28 (22–43) 39 (35–52) 31 (20–38)
aIn 9/10 subjects, HRP2 levels were below the detection level of 0.06 ng/mL.
bAbsolute lymphocyte counts from Coulter data were available for all AC and a subgroup of 11 UM and 11 SM subjects.
doi:10.1371/journal.ppat.1000402.t001
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function, assessed by proliferative responses to the recall antigen
PPD, were significantly lower in patients with SM (Median SI: 2
[IQR: 1–5]) compared to patients with UM (Median SI: 11 [IQR:
4–23]); p=0.009.
Treg frequency correlates with parasite load in SM but
not in UM
Inpatients with SM, Tregcellfrequencywascorrelatedwith both
peripheral parasitaemia (rs=0.79, p=0.0003) and parasite biomass
(rs=0.87, p,0.0001; Figure 1D). In these patients absolute Treg
cell numbers were similarly correlated (rS=0.63 [p=0.038] and
rS=0.76 [p=0.01]; respectively). In an a priori subgroup analysis,
the five 5 SM patients with hyperparasitemia (.100 parasites/1000
RBC) had a median Treg cell frequency of 3.86% [IQR: 2.2–
6.8%], significantly higher compared to SM patients without
hyperparasitaemia (median 1.4% [IQR: 0.9–2.4%]; p=0.02);
Figure 1E. In contrast, in patients with UM there was no significant
correlation between Treg cell number or frequency and peripheral
parasitemia or parasite biomass (data not shown).
Increased surface expression of TNFRII on Treg in SM
Treg cells were assessed further for expression of activation
markers. Across the groups CD4
+CD25
+Foxp3
+ T cells expressed
low levels of the IL-7 receptor CD127, but not the early activation
marker CD69 (Figure 2A). The majority of CD4
+CD25
+Foxp3
+ T
cells expressed CD45RO and expression of the lymph node homing
receptor CCR7 was low. Since Treg cells have been recently
reported to express tumor necrosis factor receptor II (TNFRII),
which may contribute to the immunosuppressive functions of these
cells [22,23], TNFRII expression was measured on CD4
+Foxp3
+C-
D127
lo T cells (Figure 2A). TNFRII expression was significantly
higher on SM CD4
+Foxp3
+CD127
lo T cells (median MFI: 8.6
[IQR: 7.5–11.5]) compared to UM (median MFI: 5.4 [IQR: 5.3–
5.4]; p=0.008) and AC CD4
+Foxp3
+CD127
lo T cells (median MFI:
7.4 [IQR: 7.4–8.2]; p=0.04); Figure 2B. Moreover, a significantly
higher frequency of CD4
+Foxp3
+CD127
lo T cells expressing
TNFR2 were found in the SM group (median 19.1% [IQR: 12.7–
25.4%]) compared to the UM (median 10.1% [IQR: 4.8–11.3%])
and AC groups (median 9% [IQR: 6.3–10.5%]); p=0.04.
In both UM and SM patients, Foxp3 expression was higher in
TNFRII
+ Treg cells (combined median MFI: 56 [IQR: 32–103])
compared to TNFRII
2 Treg cells (combined median MFI: 41
[IQR: 32–63]); p=0.04; Figure 2C. Together, these data indicate
that SM patients have higher numbers of TNFRII
+ Tregs cells
expressing high levels of Foxp3, suggesting that these cells may
have greater immunosuppressive capacity.
TNFRII-expressing Treg cells with enhanced suppressive
activity increased after exposure to P. falciparum in vitro
The relationship between P. falciparum Treg cell expansion and
activity was examined using an in vitro cell culture system to control
for extraneous variables. PBMC from malaria-unexposed donors
were cultured in vitro either alone or in the presence of parasitized
red blood cells (pRBC) or uninfected RBC (uRBC) at different ratios.
In the absence of RBC or the presence of uRBC, Treg cell frequency
declined over 6 days of culture. In contrast, co-culture with pRBC
maintained (at lower pRBC ratios) or increased (at higher pRBC
ratios) Treg cell frequencies (Figure 3A). This finding was statistically
significant using a multilevel regression model (p,0.001) [24].
TNFRII expression by CD4
+Foxp3
+CD127
lo Treg cells also
increased until at least day 6 of culture following pRBC stimulation.
Higher levels of Treg cell TNFRII expression were observed in the
presence of greater pRBC ratios (Figure 3B). In addition, supernatant
concentrations of soluble TNFRII (sTNFRII),an important Treg cell
suppressor molecule [22], also increased in the presence of greater
pRBC ratios (Figure 3C, left panel). TNF levels were highest in
cultures with high parasite ratios. In all donors, TNF levels stayed low
overthe first three days of cultureand increased rapidlyfrom day 4 in
cultures with high parasite ratios (Figure 3C, middle panel). Exposure
to high, but not low, parasite ratios triggered IL-10 secretion from as
early as 24 hours of culture (Figure 3C right panel). Together, these
in vitro data may imply a direct association between increased
parasite numbers, Treg cell TNFRII expression and cytokine
secretion, supporting the in vivo findings suggesting increased
parasite exposure may alter Treg cell function.
To assess TNFRII
+ Treg cell function, CD4
+CD25
+ T cells were
sorted based on TNFRII expression after 1–2 days of pRBC or
uRBC exposure. CD4
+CD25
+TNFRII
+ T cells were found to
express higher levels of Foxp3 than CD4
+CD25
+TNFRII
2 T cells
(Figure 3D), consistent with our earlier observations on TNFRII
+
and TNFRII
2 Treg cells from malaria-exposed individuals
(Figure 2C). The suppressive capacity of CD4
+CD25
+TNFRII
+
and CD4
+CD25
+TNFRII
2 T cells was assessed in a standard T cell
suppression assay [3] using CD4
+CD25
2 responder T cells. Sorted
CD4
+CD25
+TNFRII
+ and CD4
+CD25
+TNFRII
2 T cells were
added separately to the responder T cells at a Treg : responder T
cell ratio of 1:1. To exclude parasite-mediated changes to the
capacities of the responder T cells to proliferate, CD4
+CD25
2
responder T cells and antigen presenting cells were isolated from
PBMC cultured in the absence of parasite (uRBC co-cultures). Only
TNFRII
+ CD4
+ CD25
+ T cells (isolated following PBMC
incubation with either uRBC or pRBC) suppressed T cell
proliferation following anti-CD3 stimulation (Figure 3E) in 2/3
donors. Responder T cell proliferation was significantly decreased
in the presence of CD4
+CD25
+TNFRII
+ T cells compared to
responder T cell cultures in the absence of Treg cells (p=0.02;
Figure 3E) and compared to responder T cell proliferation in the
presence of CD4
+CD25
+TNFRII
2 T cells (p=0.04; Figure 3E).
These data suggest that TNFR2 expression is a marker of functional
Treg cells with suppressive capacity. Our data furthermore indicate
that TNFR2
+Foxp3
hi are functional regardless of parasite exposure.
TGFb and disease severity
Because TGFb induces Foxp3 expression [20], we examined
whether the Treg cell frequency was associated with plasma TGFb
Figure 1. Treg cell analysis. PBMC were stained for the cell surface markers CD4, CD25, and CD127, followed by intracellular staining for Foxp3. (A)
Lymphocytes were firstly gated on CD4 expression. All gated CD4 cells expressed CD3 (data not shown). CD4 T cells were then gated on cells
expressing Foxp3 with low expression of CD127. Only cells that also expressed CD25 were considered Treg cells. (B) Treg cell frequency was
significantly elevated in malaria patients (p=0.007 by Kruskal-Wallis test, and in post-hoc pairwise comparison with controls, UM: p=0.004, SM:
p=0.007). Treg cells are shown as the percentage of CD4 T cells. Horizontal lines depict the median with interquartile range. (C) Activated CD4 T cells
were defined as CD25+CD4 T cells without co-expression of the Foxp3+CD127
lo phenotype. Ratios of activated CD4 T cells: Treg cells are shown for
AC, UM, and SM (p=0.007 by Kruskal-Wallis test, and in post-hoc pairwise comparison with controls, UM: p=0.005, SM: p=0.009). Horizontal lines
depict the median with interquartile range. (D) Correlation of Treg cell frequency and PfHRP2 plasma levels in SM. (E) In patients with severe malaria,
Treg cells were significantly elevated in subjects with hyperparasitemia (HP) compared to SM patients without hyperparasitemia (no HP); p=0.02;
Mann-Whitney U test. AC, malaria-exposed asymptomatic controls; UM, uncomplicated P. falciparum malaria; SM, severe P. falciparum malaria.
doi:10.1371/journal.ppat.1000402.g001
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13 patients (5 AC, 3 UM and 5 SM). In this small subset, no
significant relationship was found between TGFb levels and Treg
cells frequency. To clarify this relationship, total TGFb was
therefore measured in archived platelet-free citrated plasma drawn
from separate groups of previously studied SM, UM and AC
Figure 2. Treg phenotype in UM and SM. PBMC of 3 AC, 6 UM, and 5 SM patients were stained for CD4, CD25, Foxp3, and CD127, or CD45RO,
CD69, CCR7, or TNFRII. (A) Mean fluorescent intensities (MFI) are shown for CD4
+CD25
2Foxp3
2 (solid line) and CD4
+CD25
+Foxp3
+ (dark grey) cells or
CD4
+Foxp3
+CD127
lo (light grey) cells. Dotted lines represent the isotype controls. One representative donor is shown, and activated T cells with high
expression of CD4 were gated out. (B) Pooled TNFRII MFI (3 AC, 6 UM, 5 SM). Horizontal lines show the median (p=0.005 by Kruskal-Wallis test, and in
post-hoc pairwise comparison of UM and SM: p=0.008, and between SM and AC: p=0.04). (C) Foxp3 expression is shown for TNFRII positive Treg
cells (top panel) and TNFRII negative Treg cells (bottom panel) for one representative UM and one representative SM sample. The dotted line shows
isotype control staining. AC, malaria-exposed asymptomatic controls; UM, uncomplicated P. falciparum malaria; SM, severe P. falciparum malaria.
doi:10.1371/journal.ppat.1000402.g002
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criteria. The levels of TGFb were elevated in both UM (median
5063 pg/mL; IQR: 3938–5647 pg/mL; n=20) and SM (median
4178 pg/mL; IQR: 3367–5609 pg/mL; n=18) patients, relative
to controls (median 3213 pg/mL; IQR: 1400–4552 pg/mL;
n=20; p=0.02). There was no significant difference in TGFb
levels between UM and SM patients and no significant correlation
between TGFb levels, blood parasitemia or parasite biomass (data
Figure 3. In vitro P. falciparum exposure induced Treg cell expansion, TNFRII expression, and enhanced Treg cell activity. PBMC from
healthy malaria-unexposed blood donors (n=4) were cultured overnight in the presence of P. falciparum–infected red blood cells (pRBC) at
pRBC:PBMC ratios of 2:1, 1:2.5, and 1:10, or uninfected red blood cells (uRBC) at a uRBC:PBMC ratio of 2:1 or without RBC. (A)
CD4
+CD25
+Foxp3
+CD127
lo Treg cells are represented as percentage of CD4 T cells. (B) TNFRII MFI on CD4
+ Foxp3
+CD127
lo Treg cells. (C) sTNFRII
(left panel), TNF (middle panel), and IL-10 (right panel) concentration in culture supernatants. (D) Following overnight culture with P. falciparum–
infected red blood cells (pRBC) or uninfected red blood cells (uRBC) at a RBC:PBMC ratio of 1:2.5, PBMC were sorted into CD4
+CD25
2 responder cells
and CD4
+CD25
+TNFRII
+ or CD4
+CD25
+TNFRII
2 Tregs and stained intracellularly for Foxp3. Foxp3 expression is shown for CD4
+CD25
+TNFRII
+ or
CD4
+CD25
+TNFRII
2 Treg cells (grey line) and CD4
+CD25
2 responder cells (dotted line). (E) Sorted cells were tested for suppressive activity. 10
4
CD4
+CD25
2 responder T cells sorted after uRBC exposure were incubated either alone or with TNFRII
+ or TNFRII
2 Tregs after uRBC or pRBC exposure
at a 1:1 ratio in 96 well plates pre-coated with 3 mg/mL anti-CD3 antibody (OKT-3) for 3 days. Sorted monocytes were used as APC. Bars show mean
cpm+/2SD of triplicate wells.
doi:10.1371/journal.ppat.1000402.g003
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derived factor contributing to enhanced parasite burden in SM
patients.
Increased Treg cell numbers correlate with plasma IL-10
and sTNFRII levels
IL-10 plasma levels were significantly increased in patients with
UM (median 58.3 pg/mL; IQR: 18.4–117.4 pg/mL; n=13) and
patients with SM (median 203.1 pg/mL; IQR: 61.9–636.3 pg/
mL; n=13) compared to asymptomatic control subjects (median
3.2 pg/mL; IQR: 0.4–9.3 pg/mL; n=8; p=0.002 and p=0.002,
respectively). The difference in the plasma levels of IL-10 between
patients with UM and SM was not significant. In each of the UM
and SM groups, plasma IL-10 correlated positively with Treg cell
frequency (rs=0.66; p=0.03 and rs=0.66; p=0.03, respectively).
sTNFRII plasma levels were significantly associated with
malaria disease severity (Figure 4A, p=0.0008). There was a
significant correlation between Treg cell frequency and plasma
sTNFRII in SM (rs=0.59; p=0.017), but not UM patients.
sTNFRII levels were highly correlated with both peripheral
parasitemia and parasite biomass in SM (rs=0.67; p=0.004 and
rs=0.72, p=0.004; respectively), but not in UM patients. Plasma
concentrations of total TNF (Figure 4B), as well as the
sTNFRII:TNF ratio, were significantly increased in association
with disease severity (Figure 4C), suggesting that a greater
proportion of total TNF is bound by sTNFRII in severe malaria,
potentially reducing TNF bioavailability.
Treg cell frequency and sTNFRII return to base levels after
parasite clearance
Convalescent samples were available in eight patients with
uncomplicated malaria 7–28 days after drug treatment. Of these,
six (75%) showed reduced Treg cell frequencies 7–28 days after
parasite clearance (median 0.9%, IQR: 0.7–1.1%) compared to a
median of 1.7% [IQR: 1.0–2.9%] prior to treatment (p=0.09),
falling within the range of Treg cell frequencies in AC subjects
(median 0.52% [IQR: 0.4–1.2%]). Plasma, sTNFRII levels were
also decreased in convalescent plasma (p=0.0005; Figure 4D).
These data indicate that the malaria-associated increases in
sTNFRII levels and Treg cell frequencies are transient and fall
following effective anti-parasitic drug treatment.
Discussion
We report increased CD4
+CD25
+Foxp3
+CD127
lo Treg cell
frequency in adult patients with uncomplicated and severe P.
falciparum malaria. While there was no difference in the frequency
or absolute counts of Treg cells between UM and SM patients,
patients with SM had significantly more TNFRII
+ Treg cells with
elevated Foxp3 expression. Because Foxp3 expression is directly
correlated with Treg cell suppressor activity [25], our data suggest
that Treg cell activity is increased in severe falciparum malaria.
Indeed, PBMC from patients with SM showed poor antigen-
specific proliferation relative to PBMC from patients with UM.
Although the reasons for impaired immune responses in severe
Figure 4. Elevated soluble TNFRII in malaria is associated with disease severity. (A) Plasma levels of soluble TNFRII were elevated in malaria
with significant differences between AC, UM, and SM patients. (B) Plasma TNF levels in AC, UM, and SM patients. (C) The ratio of plasma levels of
sTNFRII to TNF in AC, UM, and SM patients. (D) In UM, soluble TNFRII levels decreased in convalescence (p=0.0005; Wilcoxon-rank test). AC, malaria-
exposed asymptomatic controls; UM, uncomplicated P. falciparum malaria; SM, Severe P. falciparum malaria.
doi:10.1371/journal.ppat.1000402.g004
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greater immunosuppressive capacity of TNFRII
+ Treg cells in
patients with SM. Our in vitro data on PBMC from malaria-
unexposed donors further support that TNFRII
+ Treg cells exert
greater suppressive activity relative to TNFRII
2, which is in
accordance with recent findings in mice [20]. Increased TNFRII
+
Treg cells were found after in vitro exposure of previously malaria-
unexposed PBMC to high ratios of pRBC compared to low ratios,
suggesting a parasitemia threshold has to be overcome for their
induction. While the in vitro model may not necessarily reflect the
in vivo response, the in vitro data reflect our observations of
increased levels of this suppressive TNFRII
+Foxp3
hi Treg subset in
patients with severe malaria who had significantly higher
parasitemia and parasite biomass relative to patients with
uncomplicated malaria. Due to the cross-sectional nature of this
study, which is inherent to human studies of severe malaria, we
cannot determine whether the increase in TNFRII
+ Treg cells in
severe malaria is a cause or consequence of progression from
uncomplicated to severe disease.
In vitro assays were performed using the P. falciparum lab strain
3D7 and while we cannot exclude different reactivity in malaria-
exposed subjects it is unlikely that stimulation of PBMC from
malaria-unexposed Australian blood bank donors resulted in
antigen-specific recall of memory T cell responses to epitopes
within the 3D7 strain. Although suppressor function requires Treg
cell activation via their T cell receptor, their suppressive capacity is
not antigen specific and can promote generalized immune
suppression [26]. Furthermore, TNFRII
+ Treg cells were functional
following exposure to parasitized or unparasitized RBC suggesting
that the appearance of TNFRII
+Foxp3
hi Treg cells was unlikely to
have been promoted by mitogenic molecules from parasite extracts.
The increase in Treg cells in UM and SM indicates that the
induction of Treg cells in pre-clinical infection [13], continues into
clinical disease. This finding is further supported by the fall in Treg
cell frequency and activity following parasite clearance with drug
treatment in patients with UM. Importantly, our findings highlight
that increased Treg cell numbers are strongly associated with
peripheral parasitemia and parasite biomass in severe disease,
providing a plausible explanation for a key role of Treg cells in
parasite replication and disease severity. While Treg cells may
ameliorate potentially deleterious immune responses [11] or
endothelial cell activation [27] in severe malaria, our results
suggest that in severe disease this may occur at the cost of
impairing effector T cell-mediated constraint of parasite growth.
Because parasite replication and biomass are major determinants
of severe and fatal malaria [17–19], Treg cells may thus
exacerbate disease severity in SM.
In contrast to previous studies showing impaired TGFb in
uncomplicated and severe malaria in children [28], plasma levels
of TGFb in adults were significantly higher in both uncomplicated
and severe malaria. This pattern of TGFb elevation parallels the
pattern seen with elevated Treg cells in uncomplicated and severe
disease and is consistent with the known effects of TGFb in
inducing Foxp3 and the Treg phenotype [29]. A limitation of our
study is our inability to measure TGFb in all subjects in whom
Treg cells data were also available. Nevertheless, we speculate that
differences in the pattern of TGFb production in uncomplicated
and severe disease between adults and children may be associated
with differences in Treg responses between these two age groups.
As such, our results in adults may not be generalizable to severe
malaria in paediatric age groups in whom immune responses and
disease phenotypes differ [30].
The anti-inflammatory cytokine IL-10 has been suggested to
inhibit pro-inflammatory immune responses to malarial antigen
[31]. As found previously [32–34], we observed increased plasma
levels of IL-10 in adults with both UM and SM. The correlation
between plasma IL-10 levels and Treg cell frequency observed in
both UM and SM patients is consistent with the known association
between IL-10 and Treg cell activity [6,7]. Although this
association does not infer causality, our in vitro data shows that
IL-10 is detectable as early as 24 hours following PBMC culture in
the presence of high concentrations of pRBC as also found by
others [35]. These data lead to the speculation that IL-10 secretion
may precede and contribute to the relative increase in Treg cells
observed in vitro and ex vivo. Indeed, expansion of Foxp3
hiTreg
cells in vitro can be partially inhibited using anti-IL-10R blocking
antibody (Anja Scholzen, personal communication).
Another cytokine recently suggested to expand murine Treg
cells in vitro is TNF [36]. In our in vitro cultures, we did not
observe an increase in TNF levels until day 4 of culture. Even after
day 4 TNF concentrations remained in the pg/mL range, while
expansion of murine Treg cells required TNF concentrations in
the ng/mL [36]. For these reasons we think it is unlikely that the
relative increase in Treg cells following exposure to high pRBC
ratios is TNF-mediated. Furthermore, although plasma TNF
concentrations were significantly elevated in adults with severe P.
falciparum malaria, these remain in the low pg/mL range as also
reported by others [19,32].
Recently, the ability of Treg cells to shed large amounts of
TNFRII has been identified as a novel mechanism by which Tregs
cells can inhibit the effects of TNF [22]. TNF has been associated
with accelerated parasite clearance in falciparum malaria [37] and
clinical use of TNF inhibitors increases the risk of hyperparasite-
mia following malaria infection [38]. At low concentrations,
soluble TNFRs stabilize TNF and prolong its half-life [39],
however at high concentrations the soluble receptors compete for
TNF binding with cellular receptors, particularly membrane
bound TNF [40], thereby inhibiting TNF bioactivity [41].
Although TNFRII shedding by Treg cells may represent a further
counter-regulatory mechanism to suppress potentially deleterious
TNF-mediated inflammatory responses induced after rupture of
parasitized red blood cells [19,42], the high concentrations of
TNFRII associated with Tregs in SM may inhibit TNF bioactivity
and contribute to impaired control of parasite growth and
progression to severe disease.
In conclusion our findings support a role for Treg cells in
malaria disease progression and parasite growth during clinical
malaria and furthermore indicate that P. falciparum can expand a
potent TNFRII
+Foxp3
hi suppressor Treg cell subset that is
associated with, and may contribute to severe malaria and
hyperparasitemia in adults. Future studies are indicated in other
human populations and age groups assessing the role of this
maximally suppressive Treg subpopulation in susceptibility to
severe malaria and other inflammatory diseases. Furthermore,
differences among candidate malaria vaccines and human
populations in the function and phenotype of vaccine-induced
Tregs may influence efficacy in protecting against uncomplicated
and severe malaria.
Materials and Methods
Study site
The study was carried out in the southern lowlands of Papua,
Indonesia, where malaria transmission is perennial but unstable
with an annual incidence estimated to be 885 per 1000 person years
with both P. falciparum and P. vivax prevalent [43]. Due to economic
immigration of largely non-immune residents symptomatic malaria
and severe disease is present in all age groups [43].
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Thirty-three malaria-exposed adults participated in this study
following informed written consent. Three groups were studied: i)
asymptomatic malaria-exposed controls (AC), resident in Timika
district for at least two years, with no fever or symptoms of malaria
within the preceding two weeks, with or without asymptomatic
parasitemia (,1000 parasites/ul); ii) patients with acute uncompli-
cated falciparum malaria (UM) presenting with P. falciparum
parasitemia and fever or history of fever within 48 hours and no
alternative cause identified [44,45] iii) patients with P. falciparum and
$1 modified WHO criteria of severe malaria (SM): acute renal
failure (creatinine .265 umol/L), or hyperbilirubinemia with renal
impairment (creatinine .130 umol/L) and/or parasitemia of
.100,000 parasites/uL, or blackwater fever, or hyperparasitemia
(.10% parasitised red cells), or cerebral malaria (Glasgow coma
score ,11), or hypoglycemia [46]. In the SM cohort, 4 patients
(25%) had cerebral malaria, 5 (29%) hyperparasitemia, 12 (75%)
renal failure, 5 (29%) hyperbilirubinemia and 10 patients (59%) had
more than one WHO criterion for severe disease. Peripheral blood
mononuclear cells (PBMC) and plasma were cryopreserved and the
mean PBMC viability upon thaw was $81% (IQR 73–91%) for all
subject groups.In the UM group follow-up samples were collected 7
and 28 days after antimalarial treatment [44,45]. PBMC from
Australian Blood Bank donors were used for in vitro assays.
The study was approved by the Ethics Committees of the
National Institute of Health Research and Development, Ministry
of Health, Jakarta, Indonesia, Menzies School of Health Research,
Darwin, Australia and the Australian Red Cross Blood Service.
Flow cytometric analysis
400 000 PBMC in PBS 2% fetal calf serum were stained with anti-
CD3 (HIT3a), CD4 (RPA-T4), CD25 (M-A251), CD127 (hIL-7R-
M21), CD45RO (UCHL1), CD69 (FN50), CCR7 (3D12) all BD
Biosciences, USA, TNFRII (22235.311, R&D Systems) antibodies or
isotype controls conjugated to fluorescein isothiocyanate (FITC),
phycoerythrin (PE) or peridinin-chlorophyll-a protein (PerCP). For
Foxp3 detection, cells were resuspended in fix/perm buffer
(ebioscience, USA), stained with Foxp3 antibody (clone PCH101,
ebioscience, USA) conjugated to allophycocyanin (APC), washed,
fixed with 1% paraformaldehyde (Sigma, Australia) and acquired
using a Becton Dickinson FACScalibur with CellQuest software.
FACS data was analyzed using Weasel software (WEHI, Australia).
Parasite biomass
Total body parasite biomass was quantified by detecting plasma
concentration of P. falciparum Histidine Rich Protein 2 (PfHRP2)
using ELISA as described [18].
P. falciparum trophozoite stimulation of non-malaria–
exposed PBMCs and suppression assays
P. falciparum 3D7 was maintained in RPMI-1640 medium (JRH,
USA) supplemented with 1 mM glutamine, 11 mM glucose, 25 mM
HEPES, 0.2% (w/v) sodium bicarbonate, 200 mM hypoxanthine,
40 mg/ml gentamycin (all Sigma-Aldrich, USA), and 0.5% (w/v)
AlbuMAX II (Invitrogen, USA) in the presence of O
+ erythrocytes at
37uC in an atmosphere of 5% CO2,5 %O 2 and 90% N2.
Trophozoites were isolated on a Percoll (Amersham Biosciences,
Sweden) gradient with a yield of .95%. PBMCs collected from
healthy Australian donors with no previous malaria exposure, were
exposed in culture media to differing ratios of percoll-enriched P.
falciparum 3D7 trophozite infected RBC (pRBC) or uninfected
(uRBC) and cultured for 1–6 days. Culture supernatant was collected
for cytokine analysis (below) and cells were analyzed using flow
cytometry or sorted for suppression assays. For cell sorting, PBMC
were stained with anti-CD4, CD25 and TNFRII monoclonal
antibodies. CD4
+ populations were sorted using the FASCAria (BD
Biosciences) and CD25
2,C D 2 5
+TNFRII
+ and CD25
+TNFRII
2
cells collected at average purities of 98% (CD25
2), 61%
(CD25
+TNFRII
+)a n d8 9 %( C D 2 5
+TNFRII
2). Suppression assays
were performed as previously described [3]. Briefly, CD4
+CD25
2
responder T cells (10
4/well), isolated following culture with uRBC,
were cultured in the presence of 10
4 autologous monocytes (also
isolated following uRBC stimulation) in 96 well round bottom plates
pre-coated with 3 mg/mL anti-CD3 monoclonal antibody (OKT-3,
Biolegend). For suppression assays, autologous CD4
+C25
+TNFRII
+
or CD4
+CD25
+TNFRII
2 T cells (isolated following uRBC or pRBC
culture) were added at 1:1 ratio. After 48 hours of culture, cells were
pulsed with 1 mCi/well of
3[H]-thymidine (Amersham, UK) and
incubated for a further 16 h.
Cell proliferation
100 000 PBMC in culture media (RPMI-1640 (JRH, USA) with
5% heat inactivated human AB serum, 2 mM glutamine, 100 mg/
mL streptomycin and 100 U/mL penicillin (all Sigma-Aldrich,
USA) were incubated for 5 days in the presence of 10 mg/mL of
purified protein derivate (PPD) from Mycobaterium tuberculosis
(Statens Serum Institute, Denmark), pulsed with 1 mCi of
3[H]-
thymidine (Amersham, UK) and then incubated for a further 16 h.
Cytokine assays
The BD CBA array (BD Biosciences, USA) was used according
to the manufacturer’s instructions to measure the concentrations of
IL-10 and TNF in lithium heparin (LiH) plasma and culture
supernatant. Soluble TNFRII in LiH plasma was quantitated by
ELISA (R&D Systems, Inc. USA) according to the manufacturer’s
recommendations.
Statistical analysis
All statistical analyses used GraphPad Prism 5 (Graphpad
Software Inc., San Diego, USA). The Kruskal-Wallis test or
Mann-Whitney U test compared data among different groups.
Spearman rank test was used for correlation analyses. Mixed-
effects REML regression was used for analysis of in vitro time
course experiments. The Wilcoxon signed rank test was used for
analysis of longitudinal data. A significance level of p,0.05 was
considered statistically significant.
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